About us
Media
Press releases
- Press release 2025-05-13 "Evira presented in NHS statement - part of national obesity care for children and young people" [ENGLISH].
- Press release 2025-03-21 "Evira acquires For Life Academy and strengthens its work in childhood obesity treatment".
- Press release 2025-03-12 "Long-term digital treatment of childhood obesity outperforms conventional care".
- Press release 2022-05-31 "The first digital support for childhood obesity is now being used in Stockholm.
Articles
- Interview Health Innovation Network 2026-04-02. "Meet the adopter: Sarah Say, Evira" – on how the CEW clinic in Birmingham uses Evira [ENGLISH].
- Interview Health Innovation Network. "Meet the innovator: Malin Ramkloo, Evira" [ENGLISH].
- Article Dietisten 2023-11-21. On how Evira is used at BUMM Norrtälje.
- https://nyheter.ki.se/mobilapp-effektivt-stod-for-barn-med-obesitas
- https://medtech4health.se/evira-ett-digitalt-verktyg-for-behandling-av-barnfetma/
- https://sophianytt.se/artiklar/bast-pa-obesitasbehandling/
- https://www.dn.se/sverige/fetma-bland-barn-okade-under-pandemin/
Participation in podcasts etc.
Published research
- "Long-term results of a digital treatment tool as an add-on to pediatric obesity lifestyle treatment: a 3-year pragmatic clinical trial", Emilia Hagman, Louise Lindberg, Resthie R. Putri, Andreas Drangel, Claude Marcus, Pernilla Danielsson, International Journal of Obesity, online 12 March 2025, doi: 10.1038/s41366-025-01738-0.
- "Effect of an interactive mobile health support system and daily weight measurements for pediatric obesity treatment, a one-year pragmatical clinical trial", Emilia Hagman, Linnea Johansson, Claude Kollin, Erik Marcus, Andreas Drangel, Love Marcus, Claude Marcus, Pernilla Danielsson, International Journal of Obesity, online 31 maj 2022, doi: 10.1038/s41366-022-01146-8.
- Thesis for doctoral degree (Ph.D) 2022. Mobile Health interventions and cardiorespiratory fitness in pediatric obesity. Linnea Johansson, Karolinska Institutet.
- A novel interactive mobile health support system for pediatric obesity treatment: a randomized controlled feasibility trial. Linnea Johansson, Emilia Hagman, Pernilla Danielsson. BMC Pediatr. 2020;20:447.
Read more about our research or about childhood obesity as a challenge.
Evira has been used in clinical practice since 2018
Patients and clinical staff use Evira daily in the treatment of childhood obesity.
4500 +
Patients
Thousands of patients have received or are receiving help to treat their obesity with Evira today
1.5 years
in treatment average
This shows the median and mean for how long a patient is treated with Evira; it varies depending on the degree of obesity at the start of treatment, among other factors.
500 000+
Measurements
Half a million measurements have been carried out in the safety of the patients' own homes
−0,3
BMI-SDS
This is how much a patient's BMI-SDS (a measure of relative degree of overweight) decreases on average after one year of treatment with Evira.
7 000+
Years of treatment
Patients already contribute thousands of treatment years that we regularly analyse to improve the tool and treatment.
50
Clinics
This is how many clinics have used Evira for paediatric childhood obesity treatment in five different countries.